Differentiating Latent Tuberculosis from Active Tuberculosis Through Activation Phenotypes and Chemokine Markers HLA-DR, CD38, MCP-1, and RANTES: A Systematic Review and Meta-Analysis
Background: Latent TB infection (LTBI) affects one fourth of the global population. Currently, there is an absence of an optimal strategy for distinguishing between active tuberculosis (aTB) and LTBI. While some researchers have explored cytokines other than interferon-gamma (IFN-γ) as biomarkers, r...
Saved in:
Main Authors: | Chaimae Kadi, Narjisse Ahmadi, Anass Houdou, Imad El Badisy, Oumnia Bouaddi, Zakaria Mennane, Nouhaila Najimi, Maryam Benlamari, Saber Boutayeb, Mohamed Khalis, Noureddine EL Mtili, Fouad Seghrouchni |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/11772719241312776 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Latent Tuberculosis Infections in Different Intensity of Exposure within Moroccan Population: Influence of Age and Bacille Calmette–Guérin Vaccination
by: Chaimae Kadi, et al.
Published: (2024-12-01) -
RANTES and Chemotactic Activity in Synovial
Fluids From Patients With Rheumatoid Arthritis and
Osteoarthritis
by: Joanna Stanczyk, et al.
Published: (2005-01-01) -
Exploring the Genetic Landscape of Mycobacterium tuberculosis: Unlocking the Differences in Between Latent and Active Tuberculosis
by: Ali Akbar Velayati, et al.
Published: (2024-12-01) -
Interpretable Machine Learning Approaches for Forecasting and Predicting Air Pollution: A Systematic Review
by: Anass Houdou, et al.
Published: (2023-11-01) -
Therapeutic Drug Monitoring in the Treatment of Active Tuberculosis
by: Aylin Babalik, et al.
Published: (2011-01-01)